Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Prospective Non-interventional Study to Evaluate the Quality of Life in Belgian Patients With CIS or RRMS in Whom Interferon Beta-1a IM Treatment Has Been Initiated

NCT01272128 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT01272128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01272128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Prospective Non-interventional Study to Evaluate the Quality of Life in Belgian Patients With CIS or RRMS in Whom Interferon Beta-1a IM Treatment Has Been Initiated
Lead sponsor
Biogen
Phase
Observational
Overall status
Completed
Start date
December 31, 2012
Completion date
September 30, 2015
Enrollment
100 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis